# OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake

> **NCT05780710** · NA · RECRUITING · sponsor: **Aktiia SA** · enrollment: 35 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **OTHER:** Aktiia Optical Blood Pressure Monitoring (OBPM) device and antihypertensive drugs (monotherapy and bitherapy)
- **OTHER:** Aktiia Optical Blood Pressure Monitoring (OBPM) device and antihypertensive drugs (monotherapy)
- **OTHER:** Aktiia Optical Blood Pressure Monitoring (OBPM) device and individualized antihypertensive treatment

## Key facts

- **NCT ID:** NCT05780710
- **Lead sponsor:** Aktiia SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-29
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05780710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05780710, "OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05780710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*